Optimal risk assessment for primary prevention remains highly challenging. Recent
registries have highlighted major discrepancies between guidelines and daily practice …

After myocardial infarction (MI), patients with type 2 diabetes have an increased rate of
adverse outcomes, compared to patients without. Diabetes confers a 1.5–2-fold increase in …

Objective Our aim was to assess systemic immune-inflammation index (SII) and NT-proBNP
value either in singly or in combination to predict acute ST-elevation myocardial infarction …

Background ST-segment elevation myocardial infarction (STEMI) is associated with a
systemic and local inflammatory response with edema. However, their role at the tissue level …

Introduction Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are cardioprotective, and
canagliflozin (CANA), an SGLT2i, has been shown to improve perfusion, AMPK signaling …

Background In suspected non–ST-segment elevation myocardial infarction (NSTEMI), this
presumed diagnosis may not hold true in all cases, particularly in patients with …

Background: Cardiac troponin detected with sensitive assays can be chronically elevated, in
the absence of unstable coronary syndromes. In patients with chronic coronary artery …

Background: CMR-assessment of left ventricular (LV) systolic function and infarct size (IS)
are amongst the most powerful predictors of long-term outcomes after acute myocardial …

Recent advances in interventional and medical treatment options of patients with acute ST-
segment elevation myocardial infarction (STEMI) have significantly improved early survival …

Editorial for "MRI Investigation of the Differential Impact of Left Ventricular Ejection Fraction
After Myocardial Infarction in Elderly vs. Non-Elderly Patients to Predict Readmission for Heart …